CoreWeave's Q2 Surge Fails to Offset Recent Losses, Analysts Predict 65% Upside
CoreWeave (NASDAQ:CRWV) has seen its stock price rise to $107.73 after a strong Q2 performance, yet it still trades significantly below the $178 price target set by Cantor Fitzgerald. This target implies a potential upside of approximately 65% from current levels. The company reported a remarkable 112.3% year-over-year revenue growth, reaching $2.58 billion, and boasts a substantial backlog of around $104 billion.
Despite this positive growth, CoreWeave's stock has faced challenges, including a 27.58% decline over the past year, which has raised concerns among investors. The decline was exacerbated by a disappointing GAAP EPS of -$1.40 in Q1 2026, which missed expectations and triggered a sell-off.
For Your Trading Desk
Sponsor Spike Success.
Cantor's analyst Brett Knoblauch has raised the price target from $167 to $178, citing four key factors that support this bullish outlook. First, CoreWeave has significantly increased its capacity, energizing approximately 450 MW in a single quarter, which is more than double that of its closest competitor. Second, the company has achieved impressive revenue growth and margins, with adjusted EBITDA doubling to $1.51 billion at a 59% margin.
The third factor is the visibility of the backlog, with Cantor estimating that CoreWeave has secured about 90% of its $30 billion annual recurring revenue target for 2027. Lastly, demand for CoreWeave's services is expanding beyond its traditional hyperscaler clients, with shorter-duration, higher-margin GPU instances gaining traction.
Analysts covering CoreWeave are generally optimistic, with 36 analysts rating the stock: 5 Strong Buy, 21 Buy, 9 Hold, 1 Sell, and 1 Strong Sell. Recent revisions have leaned towards more favorable projections.
While CoreWeave's stock has climbed 50.44% year to date, it still lags behind the S&P 500's 13.28% gain. The company faces risks, including a high debt-to-equity ratio and ongoing securities fraud litigation, which could impact its future performance. However, if the backlog converts as expected and margins improve, the path to Cantor's price target may be achievable.
In summary, while CoreWeave's recent surge is promising, the stock's overall performance remains a point of concern, and investors should remain cautious as the company navigates its growth trajectory amid market challenges.




